PETRAGLIA, Felice
 Distribuzione geografica
Continente #
NA - Nord America 3.012
EU - Europa 798
AS - Asia 401
SA - Sud America 8
AF - Africa 1
OC - Oceania 1
Totale 4.221
Nazione #
US - Stati Uniti d'America 3.011
GB - Regno Unito 294
SE - Svezia 143
HK - Hong Kong 126
CN - Cina 106
UA - Ucraina 104
DE - Germania 92
SG - Singapore 68
TR - Turchia 61
IT - Italia 56
FI - Finlandia 37
BG - Bulgaria 34
IN - India 19
IE - Irlanda 10
LT - Lituania 8
PT - Portogallo 8
ID - Indonesia 7
FR - Francia 5
BR - Brasile 4
MY - Malesia 4
CO - Colombia 3
IR - Iran 3
BE - Belgio 2
KR - Corea 2
NL - Olanda 2
PK - Pakistan 2
VN - Vietnam 2
AU - Australia 1
CA - Canada 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
MD - Moldavia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 4.221
Città #
Fairfield 574
Woodbridge 298
Ashburn 294
Southend 248
Houston 242
Wilmington 206
Chandler 196
Seattle 192
Cambridge 189
Jacksonville 161
Hong Kong 124
Dearborn 121
Nyköping 108
Ann Arbor 83
Singapore 52
Izmir 41
San Diego 40
Princeton 36
Eugene 34
Sofia 34
Helsinki 26
Shanghai 23
New York 22
Beijing 20
Modena 17
Bremen 15
Dublin 10
Falls Church 10
Philadelphia 9
Redwood City 8
Jakarta 7
Kunming 7
London 7
Nanjing 7
Sesto Fiorentino 7
Bangalore 6
Boardman 6
Rome 5
Guangzhou 4
Los Angeles 4
Edison 3
Hefei 3
Jiaxing 3
Milan 3
Prescot 3
Quzhou 3
San Mateo 3
Tulare 3
Bloomfield 2
Bologna 2
Brussels 2
Chicago 2
Chiswick 2
Dong Ket 2
Fuzhou 2
Groningen 2
Kilburn 2
Nanchang 2
Naples 2
Natal 2
Norwalk 2
Oristano 2
Quattro Castella 2
Topsfield 2
Yiwu 2
Aachen 1
Acton 1
Ada 1
Ardabil 1
Austin 1
Cairo 1
Campinas 1
Charlotte 1
Chengdu 1
Chisinau 1
Cinisello Balsamo 1
Dallas 1
Des Plaines 1
Dongguan 1
Eden Prairie 1
Falkenstein 1
Harbin 1
Hebei 1
Hounslow 1
Indiana 1
Islamabad 1
Jinan 1
La Spezia 1
Lahore 1
Leawood 1
Misterbianco 1
Mountain View 1
Olomouc 1
Paris 1
Prato 1
Pune 1
Riyadh 1
Sacramento 1
Saint-Basile-le-Grand 1
Seongnam 1
Totale 3.586
Nome #
Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007 172
Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women 155
EXPOSURE TO LOW-FREQUENCY PULSED ELECTROMAGNETIC-FIELDS INCREASES INTERLEUKIN-1 AND INTERLEUKIN-6 PRODUCTION BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS 154
EFFECT OF CHRONIC INTERMITTENT STRESS ON RAT PREGNANCY AND POSTNATAL-DEVELOPMENT 149
Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor 147
Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women 146
The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study 145
Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata 145
Effects of estradiol alone or in combination with cyproterone acetate on carotid artery pulsatility index in postmenopausal women 143
The cardiovascular risk factor homocysteine is not elevated in young women with hyperandrogenism or hypoestrogenism 142
Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome 140
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives 139
8th World Congress of Gynecological Endocrinology 137
Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome 135
Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women 133
Corticotropin-releasing hormone, its binding protein and receptors in human cervical tissue at preterm and term labor in comparison to non-pregnant state 130
Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women 129
A benefit-risk assessment of medical treatment for uterine leiomyomas 129
Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density 126
Hemodynamic effect of danazol therapy in women with uterine leiomyomata 124
Effects of the selective estrogen receptor modulator, raloxifene, on carotid artery pulsatility index in postmenopausal women 121
Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women 119
Insulin-dependent diabetes in men is associated with hypothalamo-pituitary derangement and with impairment in semen quality 118
Quantitative determination of sst2 and sst5 gene expression in uterine leiomyomata and the effect of treatment with somatostatin analogue 118
Menopause, the cardiovascular risk factor homocysteine, and the effects of treatment 118
Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety 117
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome 110
High levels of fetal membrane activin beta A and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor 88
null 84
GONADOTROPIN-RELEASING-HORMONE, INBIBIN, AND ACTIVIN IN HUMAN PLACENTA - EVIDENCE FOR A COMMON CELLULAR-LOCALIZATION 82
Ultrastructural sperm analysis in men with insulin-dependent diabetes 77
Sperm chromosome aneuploidy and gonadotrophin treatment 70
null 56
Polycystic ovary syndrome and type 2 diabetes mellitus 55
Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids, and maternal serum in early pregnancy 35
CORTICOTROPIN-RELEASING HORMONE INCREASES PROSTAGLANDIN-F2-ALPHA ACTIVITY ON HUMAN MYOMETRIUM IN-VITRO 25
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 18
THE FIRST 1000 DAYS OF LIFE AND REPRODUCTIVE DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS) 11
MENSTRUATION-RELATED DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS): BLEEDING AND PAIN 11
Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases 8
Totale 4.261
Categoria #
all - tutte 19.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.692


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020981 0 0 18 79 116 176 202 131 126 37 61 35
2020/2021748 78 33 71 64 94 31 60 111 57 76 37 36
2021/2022586 14 164 57 21 5 18 49 22 59 28 103 46
2022/2023549 58 75 48 20 78 70 5 70 72 4 11 38
2023/2024372 6 24 15 59 75 28 52 44 6 4 17 42
2024/202568 50 6 12 0 0 0 0 0 0 0 0 0
Totale 4.261